Quick Takeaways
- TRIB - TRINITY BIOTECH PLC has 5 insiders with reported activity on this page.
- No net insider buy/sell flow is currently reported for the last year.
- Recent transaction rows are available for direct filing-level review.
Insider Transactions Reported by 5 Insiders of TRINITY BIOTECH PLC
- Symbol
- TRIB on Nasdaq
- Location
- Wicklow
What Changed
- No meaningful buy/sell imbalance is currently visible in the one-year window.
- Activity will update as new Forms 3/4/5 are filed.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Source Evidence
Filed on Form 4
See Original Filing
Issuer insider activity is sourced from SEC Forms 3, 4, and 5.
Insider trading overview
Last 12 monthsInsider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 15 May 2025.
Buys
$0
Shares: 0
Insiders: 0
Sells
$0
Shares: 0
Insiders: 0
Net
$0
Shares: 0
Insiders: 0
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
TRINITY BIOTECH PLC executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Andrew Omidvar | Director | Mixed | 18 Mar 2026 | |||
| John Gillard | Director | Mixed | 18 Mar 2026 | |||
| John Paul Tivnan | Director | Mixed | 18 Mar 2026 | |||
| Paul Murphy | Interim CFO | Mixed | 18 Mar 2026 | |||
| Ronan O'Caoimh | Director | Mixed | 18 Mar 2026 |
Top shareholders of TRINITY BIOTECH PLC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13D/G
|
— |
9.9%
|
3,424,019,957
|
$2,431,054,169 | +$1,392,282,813 | 30 Apr 2026 | |
| MiCo IVD Holdings, LLC |
13D/G
|
— |
17%
|
69,450,720
|
$62,505,648 | $0 | 08 Dec 2025 | |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0%
|
526,610
|
$417,000 | — | 31 Dec 2025 | |
| Williams & Novak, LLC |
13F
|
Company |
0%
|
93,300
|
$73,800 | — | 31 Dec 2025 | |
| Moss Adams Wealth Advisors LLC |
13F
|
Company |
0%
|
25,666
|
$20,302 | — | 31 Dec 2025 | |
| INSPIRION WEALTH ADVISORS, LLC |
13F
|
Company |
0%
|
25,000
|
$19,775 | — | 31 Dec 2025 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0%
|
22,280
|
$18,000 | — | 31 Dec 2025 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0%
|
20,319
|
$16,072 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0%
|
20,262
|
$16,027 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0%
|
18,650
|
$14,752 | — | 31 Dec 2025 | |
| BECKER CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
18,000
|
$14,238 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0%
|
16,642
|
$13,163 | — | 31 Dec 2025 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0%
|
15,797
|
$12,495 | — | 31 Dec 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0%
|
14,249
|
$11,271 | — | 31 Dec 2025 | |
| LPL Financial LLC |
13F
|
Company |
0%
|
12,685
|
$10,034 | — | 31 Dec 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
6,371
|
$5,038 | — | 31 Dec 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
3,804
|
$3,009 | — | 31 Dec 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
2,500
|
$1,975 | — | 31 Dec 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
2,000
|
$1,582 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
1,000
|
$1,000 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,095
|
$867 | — | 31 Dec 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
1,000
|
$791 | — | 31 Dec 2025 | |
| Triumph Capital Management |
13F
|
Company |
0%
|
1,000
|
$791 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0%
|
780
|
$617 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
580
|
$459 | — | 31 Dec 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
222
|
$176 | — | 31 Dec 2025 | |
| ATWOOD & PALMER INC |
13F
|
Company |
0%
|
20
|
$16 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
11
|
$9 | — | 31 Dec 2025 | |
| CoreCap Advisors, LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 31 Dec 2025 | |
| Novus Diagnostics Ltd. |
13D/G
|
— |
6%
|
1,119,988
|
— | $0 | 23 Dec 2025 | |
| Ronan O'Caoimh |
3/4/5
|
Director |
—
class O/S missing
|
486,208
|
— | — | 18 Mar 2026 | |
| John Gillard |
3/4/5
|
Director |
—
class O/S missing
|
10,000
|
— | — | 18 Mar 2026 |
Recent Insider Transactions by Companies or Individuals for TRINITY BIOTECH PLC
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Ronan O'Caoimh | TRIB | ADS | 0 | 486,208 | 18 Mar 2026 | Direct | ||||
| John Gillard | TRIB | ADS | 0 | 10,000 | 18 Mar 2026 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.